Search Results - "Waclaw, Joanna"

Long-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with imatinib: a 20-year single-centre experience by Szczepanek, Elżbieta, Chukwu, Ositadima, Kamińska, Magdalena, Wysogląd, Hubert, Cenda, Agnieszka, Zawada, Magdalena, Jakóbczyk, Małgorzata, Wącław, Joanna, Sacha, Tomasz

“…We report on long-term outcomes of 267 patients (pts) with chronic myeloid leukemia (CML) treated with imatinib administered as initial therapy. The median…”
Get full text

A multicenter prospective study on efficacy and safety of imatinib generics: A report from Polish Adult Leukemia Group imatinib generics registry by Sacha, Tomasz, Góra‐Tybor, Joanna, Szarejko, Monika, Bober, Grażyna, Grzybowska‐Izydorczyk, Olga, Niesiobędzka‐Krężel, Joanna, Dudziński, Marek, Wasilewska, Ewa, Myśliwiec, Krzysztof, Gil, Justyna, Gniot, Michał, Pietkun, Iwona, Mędraś, Ewa, Hołojda, Jadwiga, Wącław, Joanna, Giannopoulos, Krzysztof

Get full text

Quality of Life and Adherence to Therapy in Patients With Chronic Myeloid Leukemia Treated With Nilotinib as a Second-Line Therapy: A Multicenter Prospective Observational Study by Sacha, Tomasz, Góra-Tybor, Joanna, Wąsak-Szulkowska, Ewa, Kyrcz-Krzemień, Sławomira, Mędraś, Ewa, Becht, Rafał, Bober, Grażyna, Kotowska, Aneta, Wącław, Joanna, Hellmann, Andrzej

“…To evaluate quality of life (QOL) and adherence to nilotinib used as second-line therapy in 177 chronic myeloid leukemia patients in chronic phase, a…”
Get full text

Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis: A Retrospective Analysis of 527 Patients From the Polish Adult Leukemia Group Registry by Gora-Tybor, Joanna, Sacha, Tomasz, Wącław, Joanna, Niesiobędzka-Krężel, Joanna, Grzybowska-Izydorczyk, Olga, Mędraś, Ewa, Dereń-Wagemann, Izabela, Patkowska, Elżbieta, Seferyńska, Ilona, Lewandowski, Krzysztof, Wache, Anna, Blajer-Olszewska, Beata, Wątek, Marzena, Kotwica-Mojzych, Katarzyna, Wasilewska, Ewa, Warzocha, Krzysztof, Jamroziak, Krzysztof

Get full text

Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy by Racil, Zdenek, Koritakova, Eva, Sacha, Tomasz, Klamova, Hana, Belohlavkova, Petra, Faber, Edgar, Rea, Delphine, Malaskova, Ludmila, Prochazkova, Jirina, Zackova, Daniela, Voglova, Jaroslava, Wącław, Joanna, Cetkovsky, Petr, Zak, Pavel, Mayer, Jiri

Get full text

Nowe metody diagnostyczne w prognozowaniu i śledzeniu odpowiedzi na leczenie inhibitorami kinaz tyrozynowych przewlekłej białaczki szpikowej by Wącław, Joanna, Sacha, Tomasz

“…Techniques of molecular biology are of key importance in diagnostics and monitoring of tyrosine kinase inhibitors (TKIs) treatment response of chronic myeloid…”
Get full text

Long-Term Outcomes of Imatinib Real-Life Treatment for Chronic Myeloid Leukemia- a 20-Year Review by Szczepanek, Elzbieta, Chukwu, Ositadima, Kaminska, Magdalena, Wysoglad, Hubert, Cenda, Agnieszka, Waclaw, Joanna, Zawada, Magdalena, Jakobczyk, Magdalena, Sacha, Tomasz

“…▪ Introduction Imatinib, approved as first-line treatment for patients with newly diagnosed chronic myeloid leukemia (CML) by FDA approximately 20 years ago,…”
Get full text

Impact of Cytoreductive Drugs upon Outcomes in a Contemporary Cohort of Adolescent and Young Adults with Essential Thrombocythemia and Polycythemia Vera by Beauverd, Yan, Ianotto, Jean-Christophe, Thaw, Kyaw Htin, Sobas, Marta, Sadjadian, Parvis, Curto-Garcia, Natalia, Shih, Lee-Yung, Devos, Timothy, Krochmalczyk, Dorota, Galli, Serena, Bieniaszewska, Maria, Seferynska, Ilona, McMullin, Mary Frances, Armatys, Anna, Spalek, Adrianna, Waclaw, Joanna, Zdrenghea, Mihnea Tudor, Legros, Laurence, Girodon, Francois, Lewandowski, Krzysztof, Angona Figueras, Anna, Samuelsson, Jan, Abuin Blanco, Aitor, Cony-Makhoul, Pascale, Collins, Angela, James, Chloe, Kusec, Rajko, Lauermannova, Marie, Noya, Maria Soledad, Skowronek, Malgorzata, Szukalski, Lukasz, Szmigielska-Kaplon, Anna, Wondergem, Marielle, Dudchenko, Iryna, Gora-Tybor, Joanna, Laribi, Kamel, Kulikowska De Nalecz, Anna, Demory, Jean-Loup, Le Du, Katell, Zweegman, Sonja, Besses Raebel, Carlos, Skoda, Radek C., Giraudier, Stephane, Griesshammer, Martin, Kiladjian, Jean-Jacques, Harrison, Claire N

“…Introduction Essential thrombocythemia (ET) and polycythemia vera (PV) are well described in adolescent and young adults (AYA) patients (pts); the most…”
Get full text

Concomitant Medications and Comorbidities Affect Early Response in CML Patients Treated with Imatinib: A Retrospective Analysis of 340 Patients from the Polish Adult Leukemia Group (PALG) Registry by Gora Tybor, Joanna, Sacha, Tomasz, Waclaw, Joanna, Niesiobedzka-Krezel, Joanna, Grzybowska-Izydorczyk, Olga, Medras, Ewa, Deren-Wagemann, Izabela, Patkowska, Elzbieta, Seferynska, Ilona, Lewandowski, Krzysztof, Wache, Anna, Blajer-Olszewska, Beata, Watek, Marzena, Wasilewska, Ewa, Stoklosa, Tomasz, Warzocha, Krzysztof, Jamroziak, Krzysztof

“…Background : It has been consistently shown that early molecular response is associated with positive long-term outcome in terms of overall survival and…”
Get full text

Myeloproliferative Neoplasms in Patients below 25 Years Old at Diagnosis: A Retrospective International Cooperative Work by Jean-Christophe, Ianotto, Kiladjian, Jean-Jacques, Sobas, Marta, Sadjadian, Parvis, Shih, Lee-Yung, Bieniaszewska, Maria, Seferynska, Ilona, McMullin, Mary Frances, Waclaw, Joanna, Legros, Laurence, Lewandowski, Krzysztof, Zdrenghea, Mihnea, Abuin Blanco, Aitor, Armatys, Anna, Samuelsson, Jan, Spalek, Adrianna, Angola Figueras, Anna, Lauermannova, Marie, Noya, María-Soledad, Czyż, Jarosław, Szmigielska-Kaplon, Anna, Kusec, Rajko, Gora Tybor, Joanna, Masternak, Anna, Michiels, Jan J., Skowronek, Malgorzata, Demory, Jean-Loup, Le Du, Katell, Zweegman, Sonja, Besses Raebel, Carlos, Giraudier, Stephane, Griesshammer, Martin, Harrison, Claire N.

“…Myeloproliferative neoplasms (MPN) are most common in old people (>60 years) and are rarely identified in children and young adults where information about…”
Get full text

Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis: A Retrospective Analysis of 470 Patients from the Polish Adult Leukemia Group (PALG) Registry by Gora-Tybor, Joanna, Sacha, Tomasz, Waclaw, Joanna, Niesiobedzka, Joanna, Grzybowska-Izydorczyk, Olga, Medras, Ewa, Deren-Wagemann, Izabela, Patkowska, Elzbieta, Seferynska, Ilona, Lewandowski, Krzysztof, Wache, Anna, Blajer-Olszewska, Beata, Watek, Marzena, Warzocha, Krzysztof, Jamroziak, Krzysztof

“…Background:Introducing tyrosine kinase inhibitors (TKIs) for treating chronic myeloid leukemia (CML) has changed the prognosis of this disease from an…”
Get full text

Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs by Sobas, Marta, Kiladjian, Jean-Jacques, Beauverd, Yan, Curto-Garcia, Natalia, Sadjadian, Parvis, Shih, Lee Yung, Devos, Timothy, Krochmalczyk, Dorota, Galli, Serena, Bieniaszewska, Maria, Seferynska, Ilona, McMullin, Mary Frances, Armatys, Anna, Spalek, Adrianna, Waclaw, Joanna, Zdrenghea, Mihnea, Legros, Laurence, Girodon, François, Lewandowski, Krzysztof, Angona Figueras, Anna, Samuelsson, Jan, Abuin Blanco, Aitor, Cony-Makhoul, Pascale, Collins, Angela, James, Chloé, Kusec, Rajko, Lauermannova, Marie, Noya, Maria Sol, Skowronek, Malgorzata, Szukalski, Lukasz, Szmigielska-Kaplon, Anna, Wondergem, Marielle, Dudchenko, Iryna, Gora Tybor, Joanna, Laribi, Kamel, Kulikowska de Nalecz, Anna, Demory, Jean-Loup, Le Du, Katell, Zweegman, Sonja, Besses Raebel, Carlos, Skoda, Radek, Giraudier, Stéphane, Griesshammer, Martin, Harrison, Claire N., Ianotto, Jean-Christophe

“…Myeloproliferative neoplasms (MPNs) are uncommon in children/young adults. Here, we present data on unselected patients diagnosed before 25 years of age…”
Get full text

Imatinib in the treatment of chronic myeloid leukemia: current perspectives on optimal dose by Waclaw, Joanna, Sacha, Tomasz, Stoklosa, Tomasz

“…Imatinib was the first tyrosine kinase inhibitor (TKI), successfully used in a clinical setting. It inhibits activity of BCR-ABL1 oncogenic tyrosine kinase…”
Get full text

Comparison of ABL1 and Gusb Reference Genes in the qRT-PCR Analysis of Halving Time and Early Molecular Response to TKI Therapy in Patients with Chronic Myeloid Leukemia by Wącław, Joanna, Zawada, Magdalena, Czekalska, Sylwia, Ochrem, Bogdan, Sacha, Tomasz

“…Objectives and background: Early molecular response (EMR) to tyrosine kinase inhibitors (TKI) therapy defined as BCR-ABL1 transcript level ≤ 10% at 3 months is…”
Get full text

Aktualne miejsce nilotynibu i dazatynibu w leczeniu przewlekłej białaczki szpikowej by Sacha, Tomasz, Wącław, Joanna

“…Tyrosine kinase inhibitors (TKI) have revolutionized the practise of treatment of chronic myeloid leukemia. The emergence of resistance to imatinib – first TKI…”
Get full text

Imatinib Generics in Treatment of Chronic Myeloid Leukemia; A Prospective Observation in Large Cohort of Patients from Polish (PALG) Imatinib Generics Registry by Sacha, Tomasz, Gora-Tybor, Joanna, Szarejko, Monika, Bober, Grażyna, Grzybowska-Izydorczyk, Olga, Niesiobędzka-Krężel, Joanna, Dudziński, Marek, Wasilewska, Ewa, Myśliwiec, Krzysztof, Gil, Justyna, Gniot, Michał, Pietkun, Iwona, Mędraś, Ewa, Wącław, Joanna, Giannopoulos, Krzysztof

“…▪ Background: Generic imatinib is already available in several countries. The use of generic imatinib is expected to lower the cost of CML therapy, however the…”
Get full text

Quality of life and adherence to therapy in patients with chronic myeloid leukemia treated with nilotinib as a second line therapy: a multicener prospective observational study by Sacha, Tomasz, Góra-Tybor, Joanna, Wąsak-Szulkowska, Ewa, Kyrcz-Krzemień, Sławomira, Mędraś, Ewa, Becht, Rafał, Bober, Grażyna, Kotowska, Aneta, Wącław, Joanna, Hellmann, Andrzej

“…Abstract Introduction The aim of this study was to evaluate quality-of-life (QOL) and adherence to the therapy in patients with chronic myeloid leukemia in…”
Get full text